Competitive vendor landscape

The global automated breast ultrasound systems (ABUS) market is highly competitive with major vendors such as GE Healthcare; Hitachi, Ltd.; Koninklijke Philips N.V.; Siemens Healthineers AG; and SonoCiné competing on the basis of price, quality, and market presence.

Top five automated breast ultrasound systems (ABUS) market vendors

GE Healthcare

GE Healthcare is one of the most popular companies in the global healthcare landscape, which operates under two business segments, namely healthcare systems and life sciences. The company offers Invenia ABUS 2.0, which uses 3D ultrasound technology to image women with dense breast tissue.

Hitachi, Ltd.

Hitachi, Ltd. is a leading manufacturer of information & telecommunication systems, social infrastructure & industrial systems, electronic systems & equipment, construction machinery, high functional materials & components, automotive systems, and smart life & eco-friendly systems. The company’s key offering in this market includes SOFIA, which provides a fully automated scan procedure with whole breast image acquisition.

Koninklijke

Koninklijke owns and operates various businesses including personal health, diagnosis & treatment, connected care & health informatics, and others. The company offers Philips EPIQ and Affiniti ultrasound systems, which come equipped with an integrated eL18-4 transducer and anatomical intelligence for proper imaging of the breast with high tissue density.

Siemens Healthineers AG

Siemens Healthineers AG operates under three segments, namely imaging, diagnostics, and advanced therapies. The key offering of the company in the ABUS market include ACUSON S2000 ABVS, which provides a 3D total breast ultrasound to identify lesions or other areas of concern in fatty and dense breast tissue.

SonoCiné

SonoCiné offers technology products which are used for vascular, orthopedic ultrasound, breast, echocardiography, MRI, and CT scan applications. The company offers SonoCiné AWBUS, which provides consistent, repeatable scan of the whole breast, including the axilla, for proper detection of cancer.

Looking for more information on this market? Request a free sample report

Browse Related Reports:

Global Digital Breast Tomosynthesis Market 2019-2023 - The market research study identifies FUJIFILM, GE Healthcare, GMM (IMS GIOTTO), Hologic, PLANMECA (PLANMED), and Siemens Healthineers, as the leading players in the global digital breast tomosynthesis market.

Global Breast Cancer Therapeutics Market 2019-2023 - The market research study identifies AstraZeneca, Eli Lilly, F. Hoffmann-La Roche, Novartis, and Pfizer, as the leading players in the global breast cancer therapeutics market